Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2002 4
2003 1
2004 2
2005 7
2006 3
2007 3
2008 6
2009 1
2010 10
2011 6
2012 4
2013 11
2014 9
2015 13
2016 11
2017 10
2018 17
2019 15
2020 21
2021 20
2022 18
2023 16
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

197 results

Results by year

Filters applied: . Clear all
Page 1
Animal models to study cognitive impairment of chronic kidney disease.
Imenez Silva PH, Pepin M, Figurek A, Gutiérrez-Jiménez E, Bobot M, Iervolino A, Mattace-Raso F, Hoorn EJ, Bailey MA, Hénaut L, Nielsen R, Frische S, Trepiccione F, Hafez G, Altunkaynak HO, Endlich N, Unwin R, Capasso G, Pesic V, Massy Z, Wagner CA, Consortium C. Imenez Silva PH, et al. Among authors: capasso g. Am J Physiol Renal Physiol. 2024 Apr 18. doi: 10.1152/ajprenal.00338.2023. Online ahead of print. Am J Physiol Renal Physiol. 2024. PMID: 38634137 Review.
Efficacy of erythropoietin as a neuroprotective agent in CKD-associated cognitive dysfunction: A literature systematic review.
Barbieri M, Chiodini P, Di Gennaro P, Hafez G, Liabeuf S, Malyszko J, Mani LY, Mattace-Raso F, Pepin M, Perico N, Simeoni M, Zoccali C, Tortorella G, Capuano A, Remuzzi G, Capasso G, Paolisso G; CONNECT Action (Cognitive Decline in Nephro-Neurology European Cooperative Target) collaborators. Barbieri M, et al. Among authors: capasso g. Pharmacol Res. 2024 May;203:107146. doi: 10.1016/j.phrs.2024.107146. Epub 2024 Mar 16. Pharmacol Res. 2024. PMID: 38493928 Free article. Review.
Drugs with a negative impact on cognitive functions (Part 2): drug classes to consider while prescribing in CKD patients.
Hafez G, Malyszko J, Golenia A, Klimkowicz-Mrowiec A, Ferreira AC, Arıcı M, Bruchfeld A, Nitsch D, Massy ZA, Pépin M, Capasso G, Mani LY, Liabeuf S; CONNECT Action (Cognitive Decline in Nephro-Neurology European Cooperative Target). Hafez G, et al. Among authors: capasso g. Clin Kidney J. 2023 Sep 18;16(12):2378-2392. doi: 10.1093/ckj/sfad239. eCollection 2023 Dec. Clin Kidney J. 2023. PMID: 38046029 Free PMC article. Review.
Drugs with a negative impact on cognitive function (Part 1): chronic kidney disease as a risk factor.
Liabeuf S, Pešić V, Spasovski G, Maciulaitis R, Bobot M, Farinha A, Wagner CA, Unwin RJ, Capasso G, Bumblyte IA, Hafez G; CONNECT Action (Cognitive Decline in Nephro-Neurology European Cooperative Target). Liabeuf S, et al. Among authors: capasso g. Clin Kidney J. 2023 Sep 18;16(12):2365-2377. doi: 10.1093/ckj/sfad241. eCollection 2023 Dec. Clin Kidney J. 2023. PMID: 38045996 Free PMC article. Review.
The SGLT2 inhibitor dapagliflozin improves kidney function in glycogen storage disease XI.
Trepiccione F, Iervolino A, D'Acierno M, Siccardi S, Costanzo V, Sardella D, De La Motte LR, D'Apolito L, Miele A, Perna AF, Capolongo G, Zacchia M, Frische S, Nielsen R, Staiano L, Sambri I, De Cegli R, Unwin R, Eladari D, Capasso G. Trepiccione F, et al. Among authors: capasso g. Sci Transl Med. 2023 Nov;15(720):eabn4214. doi: 10.1126/scitranslmed.abn4214. Epub 2023 Nov 1. Sci Transl Med. 2023. PMID: 37910600
Neuropeptide Y gene polymorphisms and chronic kidney disease progression.
Spoto B, Mallamaci F, Politi C, Parlongo RMT, Leonardis D, Capasso G, Tripepi G, Zoccali C. Spoto B, et al. Among authors: capasso g. J Hypertens. 2024 Feb 1;42(2):267-273. doi: 10.1097/HJH.0000000000003600. Epub 2023 Oct 18. J Hypertens. 2024. PMID: 37889542
Methodological challenges and biases in the field of cognitive function among patients with chronic kidney disease.
Giannakou K, Golenia A, Liabeuf S, Malyszko J, Mattace-Raso F, Farinha A, Spasovski G, Hafez G, Wiecek A, Capolongo G, Capasso G, Massy ZA, Pépin M. Giannakou K, et al. Among authors: capasso g. Front Med (Lausanne). 2023 Aug 9;10:1215583. doi: 10.3389/fmed.2023.1215583. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37621458 Free PMC article. Review.
197 results